Search Results - "Denomme, G."

Refine Results
  1. 1
  2. 2

    High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes by Denomme, G.A., Van Oene, M.

    Published in Transfusion (Philadelphia, Pa.) (01-05-2005)
    “…BACKGROUND: Transfusion recipients who become alloimmunized to red cell or platelet (PLT) antigens require antigen‐negative blood to limit adverse transfusion…”
    Get full text
    Journal Article
  3. 3

    Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma by Pecker, L. H., Timsar, A., Pary, P. P., Denomme, G. A., Criss, V. R., Luban, N. L. C., Hwang, E. I., Wong, E. C. C.

    Published in Pediatric blood & cancer (01-10-2016)
    “…Ceftriaxone‐induced immune hemolytic anemia (CIHA) is the second most common cause of drug‐induced hemolytic anemia. Prompt recognition of this drug reaction…”
    Get full text
    Journal Article
  4. 4

    Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4 by KELTON, J. G, SMITH, J. W, WARKENTIN, T. E, HAYWARD, C. P. M, DENOMME, G. A, HORSEWOOD, P

    Published in Blood (01-06-1994)
    “…Heparin-induced thrombocytopenia (HIT) is an important complication of heparin therapy. Although there is general agreement that platelet activation in vitro…”
    Get full text
    Journal Article
  5. 5

    Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17 by Denomme, G.A., Ryan, G., Seaward, P.G.R., Kelly, E.N., Fernandes, B.J.

    Published in Transfusion (Philadelphia, Pa.) (01-09-2004)
    “…BACKGROUND:  Clinically significant antibodies to high‐incident antigens present a challenge in hemolytic disease of the newborn. Antigen‐negative blood may be…”
    Get full text
    Journal Article
  6. 6

    Microfluidic approach to genotyping human platelet antigens by Lim, C, Manage, D P, Atrazhev, A, Denomme, G, Backhouse, C J, Acker, J P

    Published in IET nanobiotechnology (01-06-2012)
    “…Centralised laboratories routinely determine blood types by serological and molecular methods. Current practices have limitations in terms of cost, time and…”
    Get more information
    Journal Article
  7. 7
  8. 8

    A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry by Lee, D H, Warkentin, T E, Denomme, G A, Hayward, C P, Kelton, J G

    Published in British journal of haematology (01-12-1996)
    “…Based on our previous observation that heparin-induced thrombocytopenia (HIT) sera can generate platelet microparticles from washed platelets in a…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Consortium for Blood Group Genes (CBGG): 2009 report by Denomme, G A, Westhoff, C M, Castilho, L M, St-Louis, M, Castro, V, Reid, M E

    Published in Immunohematology (01-01-2010)
    “…Consortium for Blood Group Genes is a worldwide organization whose goal is to have a vehicle to interact, establish guidelines, operate a proficiency program,…”
    Get more information
    Journal Article
  11. 11

    Consortium for Blood Group Genes (CBGG): 2008 report by Denomme, G A, Westhoff, C M, Castilho, L, Reid, M E

    Published in Immunohematology (01-01-2009)
    “…The Consortium for Blood Group Genes is a worldwide organization whose goal is to have a vehicle to interact, establish guidelines, operate a proficiency…”
    Get more information
    Journal Article
  12. 12

    Consortium for Blood Group Genes (CBGG): 2007 report by Reid, M E, Westhoff, C, Denomme, G, Castilho, L

    Published in Immunohematology (01-01-2007)
    “…The Consortium for Blood Group Genes is a worldwide organization whose goal is to have a vehicle to interact, establish guidelines, operate a proficiency…”
    Get more information
    Journal Article
  13. 13

    The structure and function of the molecules that carry human red blood cell and platelet antigens by Denomme, Gregory A

    Published in Transfusion medicine reviews (01-07-2004)
    “…A number of molecules on the surface of red blood cells (RBCs) and platelets express antigenic activity. Various biochemical and molecular approaches have been…”
    Get full text
    Journal Article
  14. 14

    Maternal immunization to Gov system alloantigens on human platelets by Bordin, José O., Kelton, John G., Warner, Margaret N., Smith, James W., Denomme, Gregory A., Warkentin, Theodore E., McGrath, Katherine, Minchinton, Robyn, Hayward, Catherine P.M.

    Published in Transfusion (Philadelphia, Pa.) (01-08-1997)
    “…BACKGROUND: Immunization to platelet alloantigens can occur during pregnancy or after the transfusion of blood components. Platelet alloantibodies can cause…”
    Get full text
    Journal Article
  15. 15
  16. 16

    An adenine trimer precedes a C/G polymorphism in the 3'-amplimer region of the human platelet glycoprotein IIIa intron 6 CT repeat by Denomme, G A

    Published in Human heredity (01-03-1998)
    “…Restriction enzyme and short tandem repeat polymorphisms are often used to link a particular allele with an inheritable disease-related gene in the absence of…”
    Get more information
    Journal Article
  17. 17

    Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia by Lee, D H, Warkentin, T E, Denomme, G A, Lagrotteria, D D, Kelton, J G

    Published in Thrombosis and haemostasis (01-01-1998)
    “…To determine whether factor V Leiden is associated with thrombotic events in patients with heparin-induced thrombocytopenia (HIT), we evaluated 165 patients…”
    Get more information
    Journal Article
  18. 18

    RhD status of a fetus at risk for haemolytic disease with a discrepant maternal DNA-based RhD genotype by Denomme, Gregory A., Akoury, Hani, Sermer, Mathew, Kelton, John G.

    Published in Prenatal diagnosis (01-05-1999)
    “…The cloning of the RHD gene has made it possible to determine the RhD status of fetuses at risk for haemolytic disease due to RhD iso‐immunization using…”
    Get full text
    Journal Article
  19. 19

    A simple and rapid competitive enzyme-linked immunosorbent assay to identify HPA-1a (PlA1)-negative donor platelet units by Denomme, G, Horsewood, P, Xu, W, Smith, J, Kelton, J

    Published in Transfusion (Philadelphia, Pa.) (01-09-1996)
    “…Alloantibodies to HPA-1a (PlA1) are the major cause of neonatal alloimmune thrombocytopenia and posttransfusion purpura and have been implicated in…”
    Get more information
    Journal Article
  20. 20

    Characterization and localization of the Gova/b alloantigens to the glycosylphosphatidylinositol-anchored protein CDw109 on human platelets by SMITH, J. W, HAYWARD, C. P. M, HORSEWOOD, P, WARKENTIN, T. E, DENOMME, G. A, KELTON, J. C

    Published in Blood (01-10-1995)
    “…The Gova/b alloantigens are expressed on a 175-kD protein (GP175) on human platelets. Anti-Gov alloantibodies have been implicated in posttransfusion purpura…”
    Get full text
    Journal Article